Literature DB >> 30269354

Potentially critical roles of TNPO1, RAP1B, ZDHHC17, and PPM1B in the progression of coronary atherosclerosis through microarray data analysis.

Xiaohui Zhang1, Renhua Sun1, Liping Liu1.   

Abstract

OBJECTIVE: This study aimed to identify more potentially critical genes associated with atherosclerotic coronary artery disease (CAD).
MATERIALS AND METHODS: Gene expression profile of GSE12288 was downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened in atherosclerotic CAD samples compared with controls, followed by weighed gene coexpression network analysis (WGCNA) by which the most significant module was identified. Gene coexpression network was constructed based on genes in the most significant module, and functional annotation was also performed. In addition, microRNAs (miRNAs) that were directly associated with CAD were screened from the literature, and the miRNA-target regulatory network was constructed based on genes in the most significant module, followed by Gene Ontology (GO) and pathway enrichment analysis. Furthermore, we used another data set of GSE42148 from the GEO database to perform data validation.
RESULTS: WGCNA analysis showed that the turquoise module may have the most important role in atherosclerotic CAD. Genes in this module were involved in translational elongation and intracellular signal transduction. Besides, we identified five confirmed CAD-related miRNAs. TNPO1, RAP1B, and ZDHHC17 could be targeted by four of these miRNAs. Genes such as PPM1B could be regulated by three miRNAs. Moreover, TNPO1 and ZDHHC17 were involved in the GO terms associated with protein localization and transport and the immune system; RAP1B and PPM1B were linked with intracellular signal transduction-related pathways. In addition, PPM1B and ZDHHC17 had accordantly significant expression changes in another data set GSE42148.
CONCLUSION: TNPO1, RAP1B, ZDHHC17, and PPM1B may play essential roles in the progression of coronary atherosclerosis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Atherosclerotic coronary artery disease (CAD); differentially expressed genes (DEG); functional enrichment analysis; weighed gene coexpression network analysis (WGCNA)

Mesh:

Substances:

Year:  2018        PMID: 30269354     DOI: 10.1002/jcb.27715

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Investigation of the underlying hub genes and mechanisms of reperfusion injury in patients undergoing coronary artery bypass graft surgery by integrated bioinformatic analyses.

Authors:  Zhida Shen; Jiangting Lu; Jiejin Wei; Juanjuan Zhao; Meihui Wang; Ming Wang; Xiaohua Shen; Xue Lü; Binquan Zhou; Yanbo Zhao; Guosheng Fu
Journal:  Ann Transl Med       Date:  2019-11

2.  Identification of Four Potential Biomarkers Associated With Coronary Artery Disease in Non-diabetic Patients by Gene Co-expression Network Analysis.

Authors:  Min Jiao; Jingtian Li; Quan Zhang; Xiufeng Xu; Ruidong Li; Peikang Dong; Chun Meng; Yi Li; Lijuan Wang; Wanpeng Qi; Kai Kang; Hongjie Wang; Tao Wang
Journal:  Front Genet       Date:  2020-06-24       Impact factor: 4.599

3.  Identification of potential crucial genes in monocytes for atherosclerosis using bioinformatics analysis.

Authors:  Yuan-Meng Zhang; Ling-Bing Meng; Si-Jun Yu; Dong-Xing Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

4.  Crucial Gene Identification in Carotid Atherosclerosis Based on Peripheral Blood Mononuclear Cell (PBMC) Data by Weighted (Gene) Correlation Network Analysis (WGCNA).

Authors:  Siliang Chen; Dan Yang; Zhili Liu; Fangda Li; Bao Liu; Yuexin Chen; Wei Ye; Yuehong Zheng
Journal:  Med Sci Monit       Date:  2020-03-11

5.  Use of bioinformatic analyses in identifying characteristic genes and mechanisms active in the progression of idiopathic thrombocytopenic purpura in individuals with different phenotypes.

Authors:  Mengyi Zhang; Binhan Guo
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.